Topic
Merger Control
485 published works
The CLS Blue Sky Blog
Sullivan & Cromwell Discusses Meta Victory in FTC Case Challenging Instagram and WhatsApp Acquisitions
By Christopher A. Graham, Renata B. Hesse, Samantha F. Hynes, Renic B. Sloan
Summary In December 2020, the FTC sued Meta, alleging that Meta held a monopoly in the market for personal social networking and had illegally maintained that monopoly through a years-long…
Cleary Antitrust Watch
EU Merger Guidelines Consultation – Our Views on Public Policy, Security, and Labour Market Considerations
By Robbert Snelders, Romi Lepetska, Séverine Schrameck, Vladimir Novak, Jon Polanec, Solenn Dietrich-Urien, Chris Spentzos, Liam Rowley
As part of our response to the European Commission’s consultation on possible reforms to its merger control guidelines,[1] we submitted our observations on Topic Paper G – Public Policy, Security,…
Cleary Antitrust Watch
The CMA Consults on Updated Guidance on Merger Remedies
By Ricardo Zimbron, Lanto Sheridan, Carolina Cury Ricciardi, Nicholas Phipps
On 16 October 2025, the CMA launched a public consultation on its draft revised Merger Remedies Guidance (the Draft Guidance).[1] The revision reflects the Government’s call for a more business-friendly,…
Cleary Antitrust Watch
EU Merger Guidelines Consultation – Our Views on Efficiencies
By Robbert Snelders, Romi Lepetska, Amaryllis Müller, Alix Anciaux, Devi Bragalini, Sanjay Kommu, Giancarlo Piscitelli, Ambroise Simon, Kimia Vaye
As part of our response to the European Commission’s consultation on possible reforms to its merger control guidelines,[1] we provided our views on Topic Paper F – Efficiencies. We…
Cleary Antitrust Watch
The French Competition Authority Imposes a EUR 7.6 Million Fine on the Group Parfait For Failure to Comply With Commitments
By François-Charles Laprévote, Hugo Gilli
On November 3, 2025, the French Competition Authority (the “FCA”) imposed a EUR 7.6 million fine on the Parfait group for failing to comply with commitments entered into in the…
Blog of Reason
Merger Remedies Are Back in Play: Recent Developments
By Benjamin H. Diessel, Robert Langer, Gabriella E. Bensur, Caitlyn Doerr
Recent merger settlements further confirm that merger remedies are back and indicate the healthcare industry remains a priority for antitrust enforcers. In July, we published an alert regarding the resolutions…
The CLS Blue Sky Blog
Arnold & Porter Discusses States’ More Active Role in Merger Settlements
By Summer Perez, Matthew Tabas
In recent years, state Attorneys General (AGs) have taken a more active approach in antitrust enforcement matters related to mergers and acquisitions. For example, earlier this year, laws in Washington…
BioSlice Blog
Article 22 Trends in Pharma M&A: Call-In Powers and Timing
By Zeno J. Frediani, Lukas Simas, Oriol Cases i Pomer
Article 22 and the Pharma Context Competition authorities in Europe have for years grown increasingly concerned about so-called “killer acquisitions,” particularly in life sciences where targets often have high innovation…
Cleary Antitrust Watch
EU Merger Guidelines Consultation – Our Views on Assessing Market Power
By Robbert Snelders, Romi Lepetska, Basak Arslan, Kristi Georgieva, Rita Pimentel Torres, Silvia Bonomelli, Agne Vaitkeviciute, Christopher Andersson, Xavier Bascompte
As part of our response to the European Commission’s consultation on possible reforms to its merger guidelines,[1] we provided our views on Topic Paper B – Assessing Market Power. The…
Cleary Antitrust Watch
EU Merger Guidelines Consultation – Our Views on Competitiveness & Resilience
By Robbert Snelders, Romi Lepetska, Elena Chutrova, Maud Lesaffre, Aleksandra Wierzbicka, Elinor du Parc
As part of our response to the European Commission’s consultation on possible reforms to its merger control guidelines,[1] we provided our views on Topic Paper A - Competitiveness and Resilience.…